112 results
8-K
EX-10.1
DMKPQ
DMK Pharmaceuticals Corp
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
and regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, advertising … of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any pharmaceutical product or drug
DEFM14A
8x825hz2zco7fihng0
13 Apr 23
Proxy related to merger
4:52pm
DEFA14A
EX-10.1
ng3o7g8r9zsz
6 Jul 22
Additional proxy soliciting materials
6:04am
8-K
EX-10.1
9gh13m5nl cm1w5u
6 Jul 22
Entry into a Material Definitive Agreement
6:04am
424B5
b2q100rybs2k5
29 Jan 21
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
jbnasa6kjb07lpr9w1w4
29 Jan 21
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:10pm
8-K
EX-99.1
dbfrkltuh0yg
28 Jan 21
Updated Summary Business Information
4:26pm
424B5
isaxmx omhsq
28 Jan 21
Prospectus supplement for primary offering
4:08pm